NYKD.OL | Nykode Therapeutics AS Annual & Quarterly

Annual Balance Sheets

(In USD)

Breakdown	2023	2022	2021	2020	2019	2018
Total Assets	2.11 Billion	2.18 Billion	2.34 Billion	1.96 Billion	293.37 Million	153.33 Million
Total Current Assets	1.68 Billion	2.08 Billion	2.25 Billion	1.96 Billion	291.5 Million	152.85 Million
Cash And Short Term Investments	1.65 Billion	2.03 Billion	2.01 Billion	1.78 Billion	279.84 Million	144.54 Million
Cash and Cash Equivalents	1.65 Billion	2.03 Billion	1.9 Billion	1.57 Billion	89.32 Million	32.44 Million
Short Term Investments	-	-	107.3 Million	213.56 Million	190.51 Million	112.1 Million
Net Receivables	10.82 Million	42.68 Million	230.64 Million	171.97 Million	11.09 Million	8.3 Million
Inventory	1.00	-	1.00	1.00	2.00	-
Other Current Assets	20.38 Million	11.36 Million	11.49 Million	1.29 Million	571.17 Thousand	-
Total Non-Current Assets	431.71 Million	94.6 Million	85.51 Million	8.52 Million	1.86 Million	483.99 Thousand
Net PPE	106.8 Million	93.84 Million	80.81 Million	3.49 Million	1.52 Million	110 Thousand
Good Will And Intangible Assets	70 Thousand	32 Thousand	32 Thousand	32 Thousand	34 Thousand	-
Good Will	-	-	-	-	-	-
Intangible Assets	70 Thousand	32 Thousand	32 Thousand	32 Thousand	34 Thousand	-
Long-Term Investments	324.2 Million	453.14 Thousand	4.41 Million	4.76 Million	35.14 Thousand	75 Thousand
Tax Assets	-	-	-	240.98 Thousand	265.76 Thousand	-
Other Non Current Assets	640.9 Thousand	283.23 Thousand	250.18 Thousand	1000.00	-1000.00	298.99 Thousand
Other Assets	-	1.00	-	-	-	1.00
Total Liabilities	375 Million	634.97 Million	630.51 Million	438.18 Million	50.57 Million	13.26 Million
Total Current Liabilities	209.28 Million	384.04 Million	276.6 Million	112.85 Million	37.94 Million	13.26 Million
Account Payables	13.47 Million	22.78 Million	24.21 Million	13.8 Million	13.37 Million	5.52 Million
Tax Payables	1.52 Million	788.08 Thousand	229.27 Thousand	1.61 Million	-	-
Short Term Debt	14.79 Million	11.29 Million	11.9 Million	2.36 Million	500.87 Thousand	-
Deferred Revenue	83.61 Million	194.41 Million	141.48 Million	-	1.00	-
Other Current Liabilities	97.4 Million	155.53 Million	99 Million	96.69 Million	24.06 Million	7.74 Million
Total Non Current Liabilities	165.72 Million	250.93 Million	353.91 Million	325.32 Million	12.62 Million	-
Long-Term Debt	4.26 Million	4.36 Million	5.82 Million	8000.00	-	-
Deferred Revenue Non Current	39.08 Million	38.63 Million	45.5 Million	60.49 Thousand	-	-
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	20.31 Thousand	295.53 Thousand	43.34 Million	58.72 Million	12.62 Million	-
Other Liabilities	1.00	-	-	1.00	-	-
Total Equity	1.73 Billion	1.54 Billion	1.71 Billion	1.53 Billion	242.8 Million	140.07 Million
Stock Holders Equity	1.73 Billion	1.54 Billion	1.71 Billion	1.53 Billion	242.8 Million	140.07 Million
Common Stock	3.72 Million	3.32 Million	2.93 Million	2.79 Million	2.77 Million	2.42 Million
Retained Earnings	300.19 Million	637.48 Million	947.57 Million	1 Billion	-289.14 Million	-150.12 Million
Accumulated other comprehensive income	125.39 Million	85.21 Million	41.8 Million	11.18 Million	9.55 Million	-
Common Stock Equity	1.73 Billion	1.54 Billion	1.71 Billion	1.53 Billion	242.8 Million	140.07 Million
Capital Lease Obligation	43.35 Million	42.99 Million	51.32 Million	68.49 Thousand	289.98 Thousand	-
Total Investments	324.2 Million	453.14 Thousand	111.72 Million	218.32 Million	190.55 Million	112.18 Million
Total Debt	58.15 Million	54.29 Million	63.22 Million	2.43 Million	790.85 Thousand	-
Net Debt	-1.59 Billion	-1.97 Billion	-1.84 Billion	-1.57 Billion	-88.53 Million	-32.44 Million

Breakdown	2024 Q2	2024 Q1	2023 Q4	2023 FY	2023 Q3	2023 Q2
Total Assets	179.87 Million	2.08 Billion	2.11 Billion	2.11 Billion	1.85 Billion	2.02 Billion
Total Current Assets	140.02 Million	1.64 Billion	1.68 Billion	1.68 Billion	1.73 Billion	1.9 Billion
Cash And Short Term Investments	136.53 Million	1.59 Billion	1.65 Billion	1.65 Billion	1.69 Billion	1.85 Billion
Cash and Cash Equivalents	136.53 Million	1.59 Billion	1.65 Billion	1.65 Billion	1.69 Billion	1.85 Billion
Short Term Investments	-	-	-	-	-	-
Net Receivables	-	49.2 Million	10.82 Million	10.82 Million	45 Million	45.41 Million
Inventory	-	-	1.00	1.00	-	-
Other Current Assets	3.48 Million	-	20.38 Million	20.38 Million	-	-
Total Non-Current Assets	39.85 Million	434.58 Million	431.71 Million	431.71 Million	118.2 Million	118.03 Million
Net PPE	9.28 Million	107.7 Million	106.8 Million	106.8 Million	117.44 Million	116.78 Million
Good Will And Intangible Assets	72 Thousand	68 Thousand	70 Thousand	70 Thousand	67 Thousand	68 Thousand
Good Will	-	-	-	-	-	-
Intangible Assets	72 Thousand	-	-	-	-	-
Long-Term Investments	-	326.14 Million	324.2 Million	324.2 Million	53.2 Thousand	503.53 Thousand
Tax Assets	-	-	-	-	-	670.23 Thousand
Other Non Current Assets	30.5 Million	669.7 Thousand	640.9 Thousand	640.9 Thousand	645.93 Thousand	1000.00
Other Assets	-	-	-	-	1.00	-
Total Liabilities	27.79 Million	359.85 Million	375 Million	375 Million	470.02 Million	526.42 Million
Total Current Liabilities	15.08 Million	195.48 Million	209.28 Million	209.28 Million	250.24 Million	278.61 Million
Account Payables	3.41 Million	43.31 Million	71.73 Million	13.47 Million	74.49 Million	75.48 Million
Tax Payables	-	-	1.52 Million	1.52 Million	883.19 Thousand	867.79 Thousand
Short Term Debt	1.39 Million	15.04 Million	14.79 Million	14.79 Million	15 Million	14.94 Million
Deferred Revenue	-	84.04 Million	83.61 Million	83.61 Million	108.78 Million	132.01 Million
Other Current Liabilities	10.27 Million	53.07 Million	39.14 Million	97.4 Million	51.95 Million	56.17 Million
Total Non Current Liabilities	12.71 Million	164.37 Million	165.72 Million	165.72 Million	219.78 Million	247.8 Million
Long-Term Debt	3.38 Million	3.74 Million	4.26 Million	4.26 Million	4.38 Million	4.68 Million
Deferred Revenue Non Current	-	36.87 Million	39.08 Million	39.08 Million	42.29 Million	45.48 Million
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	877 Thousand	9.38 Million	20.31 Thousand	20.31 Thousand	21.28 Thousand	117.84 Thousand
Other Liabilities	-	-	1.00	1.00	1.00	-
Total Equity	152.07 Million	1.72 Billion	1.73 Billion	1.73 Billion	1.38 Billion	1.49 Billion
Stock Holders Equity	152.07 Million	1.72 Billion	1.73 Billion	1.73 Billion	1.38 Billion	1.49 Billion
Common Stock	367 Thousand	3.98 Million	3.72 Million	3.72 Million	3.6 Million	3.63 Million
Retained Earnings	7.72 Million	163.97 Million	300.19 Million	300.19 Million	371.33 Million	483.6 Million
Accumulated other comprehensive income	14.99 Million	154.61 Million	125.39 Million	125.39 Million	116.16 Million	107.98 Million
Common Stock Equity	152.07 Million	1.72 Billion	1.73 Billion	1.73 Billion	1.38 Billion	1.49 Billion
Capital Lease Obligation	4.78 Million	40.61 Million	43.35 Million	43.35 Million	46.68 Million	50.17 Million
Total Investments	-	326.14 Million	324.2 Million	324.2 Million	53.2 Thousand	503.53 Thousand
Total Debt	4.78 Million	55.66 Million	58.15 Million	58.15 Million	61.68 Million	65.11 Million
Net Debt	-131.74 Million	-1.54 Billion	-1.59 Billion	-1.59 Billion	-1.63 Billion	-1.79 Billion

Balance Sheet Charts

U & I Financial Corp.

UNIF

Full Analysis

Annual Balance Sheets
Grand Ming Group Holdings Limited

1271

Full Analysis

Annual Balance Sheets
Hear AtLast Holdings, Inc.

HRAL

Full Analysis

Annual Balance Sheets
Vinyoflex Limited

VINYOFL

Full Analysis

Annual Balance Sheets
Grupo Financiero Inbursa, S.A.B. de C.V.

4FY

Full Analysis

Annual Balance Sheets
adish Co., Ltd.

7093

Full Analysis

Annual Balance Sheets

Global Stocks Search

Nykode Therapeutics AS (NYKD.OL)

Annual Balance Sheets

Balance Sheet Charts

U & I Financial Corp.

Grand Ming Group Holdings Limited

Hear AtLast Holdings, Inc.

Vinyoflex Limited

Grupo Financiero Inbursa, S.A.B. de C.V.

adish Co., Ltd.